Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 15.53 Billion INR | 1.61% |
| 2022 | 15.28 Billion INR | -13.15% |
| 2021 | 17.6 Billion INR | 48.73% |
| 2020 | 11.83 Billion INR | 31.63% |
| 2019 | 8.99 Billion INR | 9.52% |
| 2018 | 8.2 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 15.33 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 15.53 Billion INR | 1.61% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 15.53 Billion INR | 0.0% |
| 2022 Q4 | 15.28 Billion INR | 5.59% |
| 2022 FY | 15.28 Billion INR | -13.15% |
| 2022 Q3 | 14.47 Billion INR | 0.0% |
| 2021 Q4 | 17.6 Billion INR | 0.0% |
| 2021 FY | 17.6 Billion INR | 48.73% |
| 2020 FY | 11.83 Billion INR | 31.63% |
| 2019 FY | 8.99 Billion INR | 9.52% |
| 2018 FY | 8.2 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 5.481% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 84.162% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -133.046% |
| Granules India Limited | 13 Billion INR | -19.447% |
| Indoco Remedies Limited | 3.53 Billion INR | -339.999% |
| Achyut Healthcare Limited | 568 Thousand INR | -2734866.901% |
| Ajanta Pharma Limited | 8.28 Billion INR | -87.535% |
| Alkem Laboratories Limited | 26.61 Billion INR | 41.625% |
| Alpa Laboratories Limited | 136.65 Million INR | -11267.926% |
| Brooks Laboratories Limited | 96.1 Million INR | -16063.703% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -581.695% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -978.506% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -1211.521% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 75.556% |
| Eris Lifesciences Limited | 1.89 Billion INR | -721.798% |
| FDC Limited | 3.88 Billion INR | -299.462% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 38.184% |
| Gufic Biosciences Limited | 2 Billion INR | -674.863% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -14754.712% |
| Ipca Laboratories Limited | 24.71 Billion INR | 37.14% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -10258.48% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -15757.47% |
| Lasa Supergenerics Limited | 190.43 Million INR | -8057.478% |
| Laurus Labs Limited | 18.45 Billion INR | 15.82% |
| Lupin Limited | 49.53 Billion INR | 68.642% |
| Medicamen Biotech Limited | 593.75 Million INR | -2516.347% |
| Medico Remedies Limited | 163.37 Million INR | -9408.736% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -121.765% |
| Piramal Pharma Limited | 21.75 Billion INR | 28.605% |
| RPG Life Sciences Limited | 1.01 Billion INR | -1438.08% |
| Sigachi Industries Limited | 707.2 Million INR | -2096.615% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 84.258% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -571.925% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -7268.836% |
| Unichem Laboratories Limited | 7.04 Billion INR | -120.45% |
| Wanbury Limited | 360.23 Million INR | -4212.391% |
| Windlas Biotech Limited | 621.89 Million INR | -2397.968% |
| ZIM Laboratories Limited | 812.62 Million INR | -1811.649% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 54.866% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 51.21% |
| Hester Biosciences Limited | 755.81 Million INR | -1955.359% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -1323.757% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -5274.424% |
| Bal Pharma Limited | 878.11 Million INR | -1669.088% |
| Strides Pharma Science Limited | 11.26 Billion INR | -37.933% |
| Venus Remedies Limited | 1.21 Billion INR | -1176.573% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -141.648% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -119.059% |
| Shilpa Medicare Limited | 3.44 Billion INR | -350.372% |
| Aarti Drugs Limited | 4.85 Billion INR | -219.715% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -265.658% |
| Suven Life Sciences Limited | 7.08 Million INR | -219160.579% |
| Ind-Swift Limited | 640.91 Million INR | -2323.818% |
| Valiant Laboratories Limited | 100.15 Million INR | -15410.725% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -209.14% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -331.877% |
| Themis Medicare Limited | 705.74 Million INR | -2101.171% |
| Hikal Limited | 3.03 Billion INR | -411.478% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 31.836% |
| Sequent Scientific Limited | 3.46 Billion INR | -348.676% |
| Novartis India Limited | 448.6 Million INR | -3362.909% |
| Wockhardt Limited | 6.4 Billion INR | -142.728% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -20.461% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -60827.215% |
| Neuland Laboratories Limited | 3.5 Billion INR | -343.312% |
| Morepen Laboratories Limited | 2.48 Billion INR | -524.898% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -38853.39% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -1156.441% |